Long-Term Results of a Hybrid Revascularization Procedure for Peripheral Arterial Disease

Jun Okadome, Takuya Matsumoto, Yukihiko Aoyagi, Daisuke Matsuda, Shinichi Tanaka, Eisuke Kawakubo, Ryoichi Kyuragi, Kouichi Morisaki, Kenichi Homma, Kazuomi Iwasa, Takahiro Ohmine, Atsushi Guntani, Ryota Fukunaga, Yoshihiko Maehara

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

OBJECTIVE: To evaluate the efficacy of hybrid procedure for peripheral arterial disease (PAD), we compared the cases treated using the hybrid procedure with those treated using open revascularization (bypass alone) in our facilities.

MATERIALS AND METHODS: We retrospectively reviewed 204 patients who underwent revascularization for PAD between 2007 and 2013. We divided the patients into two groups based on the type of procedure. Group 1 included patients who underwent the hybrid procedure, that is, doing endovascular therapy (EVT) either femoral or iliac resion and added the bypass procedure (infragenicular vein bypass) to the below knee artery, and group 2 included patients who underwent only bypass procedure (used autovein), that is, central anastomotic region was femoral artery region and peripheral anastomotic region was below knee artery. We evaluated various factors between the two groups, including the primary patency rate, secondary patency rate, amputation-free survival rate, and determined the efficacy of the hybrid procedure for PAD.

RESULTS: In the patient's characteristics, there was significant difference between the two groups in the cases with cerebrovascular disease, only (p = 0.03). There were no significant differences in the primary or secondary patency rates, and the amputation-free survival rate.

CONCLUSIONS: Primary patency rate, secondary patency rate, and amputation-free survival rate of the hybrid procedure were comparable to those of bypass (alone) procedure. The hybrid procedure is therefore an acceptable strategy for patients with PAD.

Original languageEnglish
Pages (from-to)254-261
Number of pages8
JournalFukuoka igaku zasshi = Hukuoka acta medica
Volume106
Issue number9
Publication statusPublished - Sep 1 2015

Fingerprint

Peripheral Arterial Disease
Amputation
Survival Rate
Knee
Arteries
Cerebrovascular Disorders
Femoral Artery
Thigh
Veins

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Okadome, J., Matsumoto, T., Aoyagi, Y., Matsuda, D., Tanaka, S., Kawakubo, E., ... Maehara, Y. (2015). Long-Term Results of a Hybrid Revascularization Procedure for Peripheral Arterial Disease. Fukuoka igaku zasshi = Hukuoka acta medica, 106(9), 254-261.

Long-Term Results of a Hybrid Revascularization Procedure for Peripheral Arterial Disease. / Okadome, Jun; Matsumoto, Takuya; Aoyagi, Yukihiko; Matsuda, Daisuke; Tanaka, Shinichi; Kawakubo, Eisuke; Kyuragi, Ryoichi; Morisaki, Kouichi; Homma, Kenichi; Iwasa, Kazuomi; Ohmine, Takahiro; Guntani, Atsushi; Fukunaga, Ryota; Maehara, Yoshihiko.

In: Fukuoka igaku zasshi = Hukuoka acta medica, Vol. 106, No. 9, 01.09.2015, p. 254-261.

Research output: Contribution to journalArticle

Okadome, J, Matsumoto, T, Aoyagi, Y, Matsuda, D, Tanaka, S, Kawakubo, E, Kyuragi, R, Morisaki, K, Homma, K, Iwasa, K, Ohmine, T, Guntani, A, Fukunaga, R & Maehara, Y 2015, 'Long-Term Results of a Hybrid Revascularization Procedure for Peripheral Arterial Disease', Fukuoka igaku zasshi = Hukuoka acta medica, vol. 106, no. 9, pp. 254-261.
Okadome J, Matsumoto T, Aoyagi Y, Matsuda D, Tanaka S, Kawakubo E et al. Long-Term Results of a Hybrid Revascularization Procedure for Peripheral Arterial Disease. Fukuoka igaku zasshi = Hukuoka acta medica. 2015 Sep 1;106(9):254-261.
Okadome, Jun ; Matsumoto, Takuya ; Aoyagi, Yukihiko ; Matsuda, Daisuke ; Tanaka, Shinichi ; Kawakubo, Eisuke ; Kyuragi, Ryoichi ; Morisaki, Kouichi ; Homma, Kenichi ; Iwasa, Kazuomi ; Ohmine, Takahiro ; Guntani, Atsushi ; Fukunaga, Ryota ; Maehara, Yoshihiko. / Long-Term Results of a Hybrid Revascularization Procedure for Peripheral Arterial Disease. In: Fukuoka igaku zasshi = Hukuoka acta medica. 2015 ; Vol. 106, No. 9. pp. 254-261.
@article{ad3ed36c58704c52ada4d047da1f5723,
title = "Long-Term Results of a Hybrid Revascularization Procedure for Peripheral Arterial Disease",
abstract = "OBJECTIVE: To evaluate the efficacy of hybrid procedure for peripheral arterial disease (PAD), we compared the cases treated using the hybrid procedure with those treated using open revascularization (bypass alone) in our facilities.MATERIALS AND METHODS: We retrospectively reviewed 204 patients who underwent revascularization for PAD between 2007 and 2013. We divided the patients into two groups based on the type of procedure. Group 1 included patients who underwent the hybrid procedure, that is, doing endovascular therapy (EVT) either femoral or iliac resion and added the bypass procedure (infragenicular vein bypass) to the below knee artery, and group 2 included patients who underwent only bypass procedure (used autovein), that is, central anastomotic region was femoral artery region and peripheral anastomotic region was below knee artery. We evaluated various factors between the two groups, including the primary patency rate, secondary patency rate, amputation-free survival rate, and determined the efficacy of the hybrid procedure for PAD.RESULTS: In the patient's characteristics, there was significant difference between the two groups in the cases with cerebrovascular disease, only (p = 0.03). There were no significant differences in the primary or secondary patency rates, and the amputation-free survival rate.CONCLUSIONS: Primary patency rate, secondary patency rate, and amputation-free survival rate of the hybrid procedure were comparable to those of bypass (alone) procedure. The hybrid procedure is therefore an acceptable strategy for patients with PAD.",
author = "Jun Okadome and Takuya Matsumoto and Yukihiko Aoyagi and Daisuke Matsuda and Shinichi Tanaka and Eisuke Kawakubo and Ryoichi Kyuragi and Kouichi Morisaki and Kenichi Homma and Kazuomi Iwasa and Takahiro Ohmine and Atsushi Guntani and Ryota Fukunaga and Yoshihiko Maehara",
year = "2015",
month = "9",
day = "1",
language = "English",
volume = "106",
pages = "254--261",
journal = "Fukuoka Acta Medica",
issn = "0016-254X",
publisher = "福岡医学会",
number = "9",

}

TY - JOUR

T1 - Long-Term Results of a Hybrid Revascularization Procedure for Peripheral Arterial Disease

AU - Okadome, Jun

AU - Matsumoto, Takuya

AU - Aoyagi, Yukihiko

AU - Matsuda, Daisuke

AU - Tanaka, Shinichi

AU - Kawakubo, Eisuke

AU - Kyuragi, Ryoichi

AU - Morisaki, Kouichi

AU - Homma, Kenichi

AU - Iwasa, Kazuomi

AU - Ohmine, Takahiro

AU - Guntani, Atsushi

AU - Fukunaga, Ryota

AU - Maehara, Yoshihiko

PY - 2015/9/1

Y1 - 2015/9/1

N2 - OBJECTIVE: To evaluate the efficacy of hybrid procedure for peripheral arterial disease (PAD), we compared the cases treated using the hybrid procedure with those treated using open revascularization (bypass alone) in our facilities.MATERIALS AND METHODS: We retrospectively reviewed 204 patients who underwent revascularization for PAD between 2007 and 2013. We divided the patients into two groups based on the type of procedure. Group 1 included patients who underwent the hybrid procedure, that is, doing endovascular therapy (EVT) either femoral or iliac resion and added the bypass procedure (infragenicular vein bypass) to the below knee artery, and group 2 included patients who underwent only bypass procedure (used autovein), that is, central anastomotic region was femoral artery region and peripheral anastomotic region was below knee artery. We evaluated various factors between the two groups, including the primary patency rate, secondary patency rate, amputation-free survival rate, and determined the efficacy of the hybrid procedure for PAD.RESULTS: In the patient's characteristics, there was significant difference between the two groups in the cases with cerebrovascular disease, only (p = 0.03). There were no significant differences in the primary or secondary patency rates, and the amputation-free survival rate.CONCLUSIONS: Primary patency rate, secondary patency rate, and amputation-free survival rate of the hybrid procedure were comparable to those of bypass (alone) procedure. The hybrid procedure is therefore an acceptable strategy for patients with PAD.

AB - OBJECTIVE: To evaluate the efficacy of hybrid procedure for peripheral arterial disease (PAD), we compared the cases treated using the hybrid procedure with those treated using open revascularization (bypass alone) in our facilities.MATERIALS AND METHODS: We retrospectively reviewed 204 patients who underwent revascularization for PAD between 2007 and 2013. We divided the patients into two groups based on the type of procedure. Group 1 included patients who underwent the hybrid procedure, that is, doing endovascular therapy (EVT) either femoral or iliac resion and added the bypass procedure (infragenicular vein bypass) to the below knee artery, and group 2 included patients who underwent only bypass procedure (used autovein), that is, central anastomotic region was femoral artery region and peripheral anastomotic region was below knee artery. We evaluated various factors between the two groups, including the primary patency rate, secondary patency rate, amputation-free survival rate, and determined the efficacy of the hybrid procedure for PAD.RESULTS: In the patient's characteristics, there was significant difference between the two groups in the cases with cerebrovascular disease, only (p = 0.03). There were no significant differences in the primary or secondary patency rates, and the amputation-free survival rate.CONCLUSIONS: Primary patency rate, secondary patency rate, and amputation-free survival rate of the hybrid procedure were comparable to those of bypass (alone) procedure. The hybrid procedure is therefore an acceptable strategy for patients with PAD.

UR - http://www.scopus.com/inward/record.url?scp=84973428776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973428776&partnerID=8YFLogxK

M3 - Article

C2 - 26742218

AN - SCOPUS:84973428776

VL - 106

SP - 254

EP - 261

JO - Fukuoka Acta Medica

JF - Fukuoka Acta Medica

SN - 0016-254X

IS - 9

ER -